CD86 and neoplasm: This resulted in increased immune regulator molecules such as CTLA4, PDL1, Tim3, VISTA, LAG3, CD38, CD80, CD86, MHC Class II, and PD-L1 being presented on the surface of trogocytic tumor cells compared to non-trogocytic tumor cells.